Показано 0 из 0
Дата |
---|
08.05.2024 |
07.05.2024 |
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
15 120.00
|
13 890.00
|
15 120.00
|
14 000.00
|
|
|
6 001 512 930.00
|
|
|
|
15 300.00
|
14 900.00
|
15 720.00
|
14 910.00
|
|
|
6 313 542 390.00
|
|
|
|
16 770.00
|
15 230.00
|
16 770.00
|
15 260.00
|
|
|
17 290 306 570.00
|
|
|
|
18 050.00
|
16 940.00
|
18 120.00
|
16 940.00
|
|
|
10 927 634 120.00
|
|
|
|
17 260.00
|
16 630.00
|
20 300.00
|
18 420.00
|
|
|
113 704 883 120.00
|
|
|
|
18 330.00
|
17 090.00
|
18 420.00
|
17 140.00
|
|
|
8 097 477 200.00
|
|
|
|
18 920.00
|
17 750.00
|
19 700.00
|
17 770.00
|
|
|
13 342 163 920.00
|
|
|
|
18 870.00
|
18 870.00
|
20 100.00
|
18 900.00
|
|
|
20 318 557 480.00
|
|
|
|
19 300.00
|
18 820.00
|
20 700.00
|
19 310.00
|
|
|
45 249 832 430.00
|
|
|
|
18 230.00
|
18 220.00
|
21 200.00
|
19 250.00
|
|
|
86 541 423 340.00
|
|
IMB Dx, Inc. operates medical testing technology development businesses. The Company develops molecular diagnostic technology, genetic testing technology, and other products. IMB Dx conducts businesses in South Korea.